# SKYX Platforms Corp.: financial statements, quarterly

SKYX · Nasdaq · CIK 1598981 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/skyx.md) · [Financials](/companies/skyx/financials.md) · [Filings](/companies/skyx/filings.md) · [Insiders](/companies/skyx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skyx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.6](/filings/0001493152-24-044769.md) | [22.2 d](/filings/0001641172-25-000290.md) | [19.0](/filings/0001641172-25-010284.md) | [21.4](/filings/0001641172-25-023186.md) | [22.2](/filings/0001493152-25-021921.md) | [23.7 d](/filings/0001493152-26-013293.md) | [20.1](/filings/0001493152-26-022230.md) | [23.1](/filings/0001493152-26-037354.md) | [23.9](/filings/0001493152-25-021921.md) | [24.9 d](/filings/0001493152-26-013293.md) | [22.1](/filings/0001493152-26-022230.md) | [25.3](/filings/0001493152-26-037354.md) |
| Cost of revenue | $m | [14.9](/filings/0001493152-24-044769.md) | [15.5 d](/filings/0001493152-24-012456.md) | [13.4](/filings/0001641172-25-010284.md) | [14.9](/filings/0001641172-25-023186.md) | [15.3](/filings/0001493152-25-021921.md) | [18.1 d](/filings/0001493152-26-013293.md) | [14.4](/filings/0001493152-26-022230.md) | [16.1](/filings/0001493152-26-037354.md) | [16.3](/filings/0001493152-25-021921.md) | [17.4 d](/filings/0001493152-26-013293.md) | [15.5](/filings/0001493152-26-022230.md) | [18.0](/filings/0001493152-26-037354.md) |
| Gross profit | $m | [6.7](/filings/0001493152-24-044769.md) | [6.6 d](/filings/0001493152-24-012456.md) | [5.6](/filings/0001493152-24-019244.md) | [6.6](/filings/0001493152-24-031279.md) | [6.8](/filings/0001493152-24-044769.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(6.5)](/filings/0001493152-24-044769.md) | [(11.8) d](/filings/0001641172-25-000290.md) | [(8.9)](/filings/0001641172-25-010284.md) | [(6.2)](/filings/0001641172-25-023186.md) | [(7.6)](/filings/0001493152-25-021921.md) | [(9.4) d](/filings/0001493152-26-013293.md) | [(7.7)](/filings/0001493152-26-022230.md) | [(7.5)](/filings/0001493152-26-037354.md) | [(6.8)](/filings/0001493152-25-021921.md) | [(7.1) d](/filings/0001493152-26-013293.md) | [(8.2)](/filings/0001493152-26-022230.md) | [(7.1)](/filings/0001493152-26-037354.md) |
| Interest expense | $m | [0.7](/filings/0001493152-23-040546.md) | [0.5 d](/filings/0001493152-24-012456.md) | [0.8](/filings/0001493152-24-019244.md) | [1.2](/filings/0001641172-25-023186.md) | [1.0](/filings/0001493152-25-021921.md) | [0.9 d](/filings/0001493152-26-013293.md) | [1.3](/filings/0001493152-26-022230.md) | [1.3](/filings/0001493152-26-037354.md) | [0.8](/filings/0001493152-25-021921.md) | [0.7 d](/filings/0001493152-26-013293.md) | [1.1](/filings/0001493152-26-022230.md) | [1.1](/filings/0001493152-26-037354.md) |
| Net income | $m | [(7.2)](/filings/0001493152-24-044769.md) | [(12.3) d](/filings/0001641172-25-000290.md) | [(9.7)](/filings/0001641172-25-010284.md) | [(7.5)](/filings/0001641172-25-023186.md) | [(8.6)](/filings/0001493152-25-021921.md) | [(10.0) d](/filings/0001493152-26-013293.md) | [(9.1)](/filings/0001493152-26-022230.md) | [(8.8)](/filings/0001493152-26-037354.md) | [(7.6)](/filings/0001493152-25-021921.md) | [(7.9) d](/filings/0001493152-26-013293.md) | [(9.3)](/filings/0001493152-26-022230.md) | [(8.2)](/filings/0001493152-26-037354.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001493152-24-044769.md) | not reported | [(0.10)](/filings/0001641172-25-010284.md) | [(0.08)](/filings/0001641172-25-023186.md) | [(0.08)](/filings/0001493152-25-021921.md) | not reported | [(0.09)](/filings/0001493152-26-022230.md) | [(0.08)](/filings/0001493152-26-037354.md) | [(0.07)](/filings/0001493152-25-021921.md) | not reported | [(0.07)](/filings/0001493152-26-022230.md) | [(0.06)](/filings/0001493152-26-037354.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0001493152-24-044769.md) | not reported | [(0.10)](/filings/0001641172-25-010284.md) | [(0.08)](/filings/0001641172-25-023186.md) | [(0.08)](/filings/0001493152-24-044769.md) | not reported | [(0.09)](/filings/0001493152-26-022230.md) | [(0.08)](/filings/0001493152-26-037354.md) | not reported | not reported | [(0.07)](/filings/0001493152-26-022230.md) | [(0.06)](/filings/0001493152-26-037354.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.5](/filings/0001493152-23-040546.md) | [16.8](/filings/0001641172-25-000290.md) | [14.1](/filings/0001493152-24-019244.md) | [10.7](/filings/0001493152-24-031279.md) | [10.2](/filings/0001493152-24-044769.md) | [12.6](/filings/0001493152-26-013293.md) | [9.4](/filings/0001641172-25-010284.md) | [12.8](/filings/0001641172-25-023186.md) | [7.8](/filings/0001493152-25-021921.md) | [8.1](/filings/0001493152-26-037354.md) | [30.3](/filings/0001493152-26-022230.md) | [25.7](/filings/0001493152-26-037354.md) |
| Current assets | $m | [28.3](/filings/0001493152-23-040546.md) | [27.3](/filings/0001641172-25-000290.md) | [25.5](/filings/0001493152-24-019244.md) | [21.6](/filings/0001493152-24-031279.md) | [19.0](/filings/0001493152-24-044769.md) | [20.4](/filings/0001493152-26-013293.md) | [18.3](/filings/0001641172-25-010284.md) | [20.4](/filings/0001641172-25-023186.md) | [16.4](/filings/0001493152-25-021921.md) | [15.4](/filings/0001493152-26-037354.md) | [36.8](/filings/0001493152-26-022230.md) | [34.0](/filings/0001493152-26-037354.md) |
| Total assets | $m | [78.3](/filings/0001493152-23-040546.md) | [76.3](/filings/0001641172-25-000290.md) | [74.2](/filings/0001493152-24-019244.md) | [69.2](/filings/0001493152-24-031279.md) | [65.0](/filings/0001493152-24-044769.md) | [65.9](/filings/0001493152-26-013293.md) | [63.2](/filings/0001641172-25-010284.md) | [64.4](/filings/0001641172-25-023186.md) | [58.4](/filings/0001493152-25-021921.md) | [57.7](/filings/0001493152-26-037354.md) | [77.9](/filings/0001493152-26-022230.md) | [74.1](/filings/0001493152-26-037354.md) |
| Current liabilities | $m | [31.3](/filings/0001493152-23-040546.md) | [24.2](/filings/0001641172-25-000290.md) | [24.3](/filings/0001493152-24-019244.md) | [28.1](/filings/0001493152-24-031279.md) | [30.8](/filings/0001493152-24-044769.md) | [26.1](/filings/0001493152-26-013293.md) | [28.6](/filings/0001641172-25-010284.md) | [29.0](/filings/0001641172-25-023186.md) | [25.2](/filings/0001493152-25-021921.md) | [24.6](/filings/0001493152-26-037354.md) | [21.6](/filings/0001493152-26-022230.md) | [23.2](/filings/0001493152-26-037354.md) |
| Total liabilities | $m | [61.3](/filings/0001493152-23-040546.md) | [60.1](/filings/0001641172-25-000290.md) | [60.7](/filings/0001493152-24-019244.md) | [59.7](/filings/0001493152-24-031279.md) | [61.1](/filings/0001493152-24-044769.md) | [56.8](/filings/0001493152-26-013293.md) | [58.9](/filings/0001641172-25-010284.md) | [58.7](/filings/0001641172-25-023186.md) | [57.3](/filings/0001493152-25-021921.md) | [57.3](/filings/0001493152-26-037354.md) | [54.1](/filings/0001493152-26-022230.md) | [55.4](/filings/0001493152-26-037354.md) |
| Long-term debt | $m | [16.2](/filings/0001493152-23-040546.md) | [18.3](/filings/0001641172-25-000290.md) | [21.3](/filings/0001493152-24-019244.md) | [21.9](/filings/0001493152-24-031279.md) | [19.9](/filings/0001493152-24-044769.md) | [20.1](/filings/0001493152-26-013293.md) | [20.0](/filings/0001641172-25-010284.md) | [19.5](/filings/0001641172-25-023186.md) | [19.0](/filings/0001493152-25-021921.md) | [19.3](/filings/0001493152-26-037354.md) | [18.4](/filings/0001493152-26-022230.md) | [17.3](/filings/0001493152-26-037354.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [17.1](/filings/0001493152-24-044769.md) | [16.2](/filings/0001641172-25-000290.md) | [13.5](/filings/0001641172-25-010284.md) | [9.5](/filings/0001641172-25-023186.md) | [3.8](/filings/0001493152-25-021921.md) | [4.1](/filings/0001493152-26-013293.md) | [(0.7)](/filings/0001493152-26-022230.md) | [0.7](/filings/0001493152-26-037354.md) | [(3.8)](/filings/0001493152-25-021921.md) | [(4.6)](/filings/0001493152-26-037354.md) | [18.8](/filings/0001493152-26-022230.md) | [13.7](/filings/0001493152-26-037354.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,448) d](/filings/0001493152-24-044769.md) | [(2,906) d](/filings/0001641172-25-000290.md) | [(6,109)](/filings/0001641172-25-010284.md) | [(4,288) d](/filings/0001641172-25-023186.md) | [(2,554) d](/filings/0001493152-25-021921.md) | [(5,309) d](/filings/0001493152-26-013293.md) | [(4,325)](/filings/0001493152-26-022230.md) | [(1,985) d](/filings/0001493152-26-037354.md) | [(4,986) d](/filings/0001493152-25-021921.md) | [(1,995) d](/filings/0001493152-26-013293.md) | [(6,014)](/filings/0001493152-26-022230.md) | [(3,672) d](/filings/0001493152-26-037354.md) |
| Capital expenditure | $k | not reported | not reported | [53.6](/filings/0001493152-24-019244.md) | [226 d](/filings/0001493152-24-031279.md) | [257 d](/filings/0001493152-24-044769.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | [213](/filings/0001493152-26-022230.md) | [272 d](/filings/0001493152-26-037354.md) | [213 d](/filings/0001493152-25-021921.md) | [323 d](/filings/0001493152-26-013293.md) | [249](/filings/0001493152-26-022230.md) | [257 d](/filings/0001493152-26-037354.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.6](/filings/0001493152-23-040546.md) | [83.0](/filings/0001493152-24-019244.md) | [86.6](/filings/0001493152-24-031279.md) | [91.1](/filings/0001493152-24-044769.md) | [95.1](/filings/0001641172-25-010284.md) | [99.4](/filings/0001641172-25-023186.md) | [104](/filings/0001493152-25-021921.md) | [104](/filings/0001493152-26-022230.md) | [107](/filings/0001493152-26-037354.md) | [112](/filings/0001493152-25-021921.md) | [129](/filings/0001493152-26-022230.md) | [135](/filings/0001493152-26-037354.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 135,430,994 at 2026-07-31, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037354.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.